International Patent: USE OF NARDOSINONE IN PREVENTION OR TREATMENT OF MYOCARDIAL TOXICITY INDUCED BY ANTHRACYCLINE ANTI-TUMOR DRUGS

GENEVA, July 31 -- PINGDINGSHAN UNIVERSITY filed a patent application (CN2025/147756) for “USE OF NARDOSINONE IN PREVENTION OR TREATMENT OF MYOCARDIAL TOXICITY INDUCED BY ANTHRACYCLINE ANTI-TUMOR DRUGS”. With publication no. WO/2026/157861, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/357

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....